Gelatin

Gelatin Reactions 1680, p153 - 2 Dec 2017 Temporary anorgasmia: case report A 44-year-old woman developed temporary anorgasmia following uterine artery embolisation (UAE) with gelatin particles [Embosphere]. The woman presented at a radiology clinic for evaluation of symptomatic fibroids. Her medical history included two uncomplicated vaginal deliveries and chronic iron deficiency anaemia with intermittent asthma. Her pelvic MRI showed multiple, moderately vascularised, intramural fibroids and a small sub mucosal fibroid. Presence of adenomyosis was confirmed by a thickened junctional zone. A decision to perform UAE was made. Both uterine arteries were embolised to stasis using a right common femoral artery access by one vial of gelatin particles 300 500 microns per side. She was admitted for observation overnight and pain management with analgesia. Next day she was discharged on pain control medicines. Two and half months after UAE, she presented for routine follow-up where she reported that her menstrual cycles were lighter and shorter. She complained that following the procedure, she had become anorgasmic and was no longer able to achieve internal or external orgasm [time to reaction onset not clearly stated]. Three months after UAE, the woman regained the ability to achieve external or clitoral orgasm while it took five months to regain the internal orgasm. Author comment: "We report a rare case of temporary anorgasmia following uterine artery embolization (UAE) performed for symptomatic uterine fibroids". "Sexual dysfunction, such as anorgasmia, is a rarely reported complication of UAE." Speir E, et al. Temporary Anorgasmia Following Uterine Artery Embolization for Symptomatic Uterine Fibroids. Cardiovascular and Interventional Radiology 40: 1792-1795, No. 11, Nov 2017. Available from: URL: http://doi.org/10.1007/ s00270-017-1776-0 - USA 803284111 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Gelatin

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/gelatin-iQc5EI05dz
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39084-3
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial